Ocular Drug Delivery Technology Market report categorize the global market by Technology (Topical, Ocular Inserts, Iontophoresis, Intraocular Implants and In Situ Gel & Punctal Plugs), Disease Type (Glaucoma, Diabetic Retinopathy, Macular Degeneration), End User & Geography
The global ocular drug delivery market size valued at $67.7 billion in 2022, and is projected to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032. The ocular drug delivery market growth is driven by advancement in ocular drug delivery technology, surge in ageing population, and rise in awareness about the various eye disorders. Aged population increases susceptibility to conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy. Know More- https://www.alliedmarketresearch.com/ocular-drug-delivery-market
The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.
The major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, and increase in the number of approvals from government regulations for new ocular drug delivery techniques. Get sample copy of this report: https://goo.gl/S9nZMM
Get sample copy: http://bit.ly/2EXE0jn The major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, an increase in the number of approvals from government regulations for new ocular drug delivery techniques.
The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.
The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.
The growing cases and prevalence of chronic diseases globally is likely to accelerate the growth of drug delivery technology market in the forecast period of 2020-2027. On the other hand, launch of advanced new products and advancement in technologies will further boost various opportunities in the growth of the drug delivery technology market in the above mentioned forecast period.
The growing number of elderly persons is a large consumer of home care drug delivery devices. Expanding applications of drug delivery into niche therapeutic areas, strategic collaborations and self-administration and home care drug delivery devices represent vast opportunities for key players in this market.
European Drug Delivery Technologies and Nasal sprays Market report categorizes the European Market by Technologies (Auto Injectors, Transdermal Patches , Injectable, Ocular, Transdermal , Oral, Pulmonary, Nasal, Topical, Implantable, and Transmucosal Drug Delivery) & by Geography.
For more information kindly visit : https://www.bharatbook.com/medical-devices-market-research-reports-732747/drug-delivery-technology-route-administration-end-user-forecast.html Bharat Book Bureau provides the report, on “ Market Research Report on Drug Delivery Technology [2020] ”.The drug delivery technology market is expected to reach USD 1,504.7 billion by 2020 from USD 1,048.1 billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. The market is categorized on the basis of route of administration, end user, and region.
The growing cases and prevalence of chronic diseases globally is likely to accelerate the growth of drug delivery technology market in the forecast period of 2020-2027. On the other hand, launch of advanced new products and advancement in technologies will further boost various opportunities in the growth of the drug delivery technology market in the above mentioned forecast period.
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5%.
Drug delivery technology market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 8326.45 billion by 2027 growing at a CAGR of 7.65% in the above-mentioned forecast period. The increasing demand for effective delivery technique of biopharmaceuticals and the improvement in the ability and safety of drug by controlling the drug release in the body are the factors influencing the growth in the market.
The North American market was valued at $66.7 billion in 2012 and is poised to reach $102.2 billion by 2017. The U.S. registered a higher market share, valued at $59.3 billion in 2012 and is expected to grow at a high single digit CAGR from 2012 to 2017.
The drug delivery system market was valued at US$ 1,243,111.7 million in 2018 and it is projected to reach US$ 2,302,227.2 million in 2027; it is expected to grow at a CAGR of 7.2% from 2019 to 2027.
The drug delivery system market was valued at US$ 1,243,111.7 million in 2018 and it is projected to reach US$ 2,302,227.2 million in 2027; it is expected to grow at a CAGR of 7.2% from 2019 to 2027
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5%.
Global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025.
Global Drug Delivery Devices Market is segmented based on product type, end-user, distribution channel, and geography. https://www.bharatbook.com/healthcare-market-research-reports-920944/global-drug-delivery-trends.html
According to the latest study on “Pharmaceutical Drug Delivery to 2027 – Global Analysis and Forecasts by Route of Administration, Application, and End User,” the global pharmaceutical drug delivery was valued at US$ 1,403,082.9 million in 2019 and is projected to reach US$ 2,296,170.9 million by 2027; it is expected to grow at a CAGR of 6.6% during 2020–2027.
North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Spain Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices”, large hospitals across the country acquire or merge with medium and small hospitals to enhancing the quality of treatment... For more information on the market research report please refer to the below link: https://www.kenresearch.com/healthcare/medical-devices/spain-drug-delivery-devices/135988-91.html
Development of Biopharmaceuticals and Biosimilar Drug Delivery Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D KLE University s College of Pharmacy Belgaum-590010
Bharat Book Bureau provides the report; on “Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021” This report newly published of the global industry analysis on the advanced and targeted drug delivery market. https://www.bharatbook.com/drugs-market-research-reports-104888/advanced-targeted-drug-delivery-segmentation.html
The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.
Newly published report “ Advanced and Targeted Drug Delivery Market” is a global industry analysis and forecasts of growth at a 10.4% CAGR to $319 billion by 2021 from $168 billion today. The global market for nano-based targeted drug delivery is presented by the following sub-markets liposomes, polymers (micelles, dendrimers etc) and gold nano-particles through to 2021 with corresponding CAGR figures.
Big Market Research has announced a new Report Package "Global Pharmaceutical Packaging Market- Size, Share, Trends, Forecast, Development, Situation, Future outlook, Potential 2019" Get Complete Report at: http://www.bigmarketresearch.com/global-pharmaceutical-packaging-outlook-2014-2022-market The Global Pharmaceutical Packaging market is valued at $58.86 billion in 2014 with CAGR of 5.42% and is expected to reach $90.6 billion by 2022. Fast growth of Pharmaceutical industry and drug delivery devices are the key drivers for the growth of Market and increasing packaging cost, Challenges in emerging markets were restraining factors for the market growth. The growth of the Market lies in Pharmaceutical containers and other services in rising markets Enquire about this report at: http://www.bigmarketresearch.com/report-enquiry/325784
The South Korea Drug Delivery Devices Market report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices... To know more, Click on the link below https://www.kenresearch.com/healthcare/medical-devices/south-korea-drug-delivery-devices/135990-91.html
Biomaterials Market Highlights Biomaterials are any materials that are used to implant missing or damaged tissues. They can be natural or synthetic in nature and regardless of their origin, they are compatible to be used in place of living tissues. Biomaterials are broadly used in drug delivery as capsules or nano-shells. Generally, they are biodegradable as well as bioresorbable so that they can disappear from organism after completing their function. They can also be used as substitutes of bone, collagen membranes, regenerative dentistry as well as in bone and cartilage regeneration during an orthopedics surgery. However, high cost associated with biomaterial production, abrasive wear of implantable products, and biocompatibility issues with the products hamper the market growth. Get Free Sample Request @ https://www.marketresearchfuture.com/sample_request/2021
Ocular Therapeutix, Inc. (Ocular ) develops ophthalmic therapeutic products using hydrogel technology. The hydrogel technology consists of polyethylene glycol (PEG), widely considered an inert and biocompatible material which can be customized as per the use.
The electronic design automation market accounted to US$10.31 Bn in 2018 and is expected to grow at a CAGR of 12.0% during the forecast period 2019 – 2027, to account to US$28.27 Bn by 2027
mHealth Market in Asia-Pacific to reach $14.4 Billion, by 2020. Asia Pacific mHealth market projects a remarkable growth rate, supplemented with the growing awareness of mHealth devices and services that aid in improve the quality of life for patients stricken with lifestyle diseases. Get sample copy of this report: https://goo.gl/c2ro2C
The U.S. compounding pharmacies market report tracks some of the key companies operating in the market, which include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Inc., Fagron N.V., Wedgewood Pharma, PharMEDium Services LLC, Doughertys Pharmacy, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Village Compounding Pharmacy
The automotive lubricants market is expected to exceed more than 475 million Gallons by 2021; Growing at a CAGR of more than 8% in the given forecast period.
Are current methods used for measuring drug levels in blood and tissues adequate ... from drug exposure, due to the extensive pre-clinical evaluation of new drugs. ...
A recent market study published by FMI “Compounding Pharmacies Market: U.S. Industry Analysis 2013-2017 & Forecast 2018-2028” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the compounding pharmacies market, the growth prospects of the market are obtained with maximum precision.
According to Prevent Blindness statistics, the prevalence of diabetic retinopathy in the U.S. is estimated to be 5.3%. VEGF-A antagonist is largely prescribed for the diabetic retinopathy treatment and also for treatment of diabetic macular edema.
Compounding pharmacies are gathering significant momentum, on account of rising demand for ‘made-to-order’ medications offering exceptional benefits for specific patients, unlike commercially available drugs. Over the past few years, there has been a significant escalating footfall in compounding pharmacies, wherein patients seek effective medications to fulfill their personal needs.
Pharmaceutical Packaging Market by Type, Material, Mode and Region, Global Forecasts 2020 to 2025. Higher packaging costs are likely to reduce market growth due to strict legislation and counterfeiting.